Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Publication of Moffitt Cancer Center Research on PV-10 for Head and Neck Cancer | 3 | GlobeNewswire (USA) | ||
18.06. | PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
09.06. | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Investor Webinar for 2025 Annual Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
16.05. | PROVECTUS BIOPHARMACEUTICALS, INC. - 10-K/A, Annual Report | 1 | SEC Filings | ||
14.05. | PROVECTUS BIOPHARMACEUTICALS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
16.04. | PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
22.01. | PROVECTUS BIOPHARMACEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
PROVECTUS Aktie jetzt für 0€ handeln | |||||
14.01. | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus's Spinoff Company for Rose Bengal-Based Eye Drugs | 9 | GlobeNewswire (USA) | ||
11.12.24 | Provectus Biopharmaceuticals Inc.: Provectus Biopharmaceuticals Launches VisiRose, Provectus's Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology | 165 | GlobeNewswire (Europe) | KNOXVILLE, Tenn., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company") (OTCQB: PVCT) announced today the launch of VisiRose, Inc. ("VisiRose"), Provectus's... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 58,76 | +0,19 % | Buy or Goodbye?: Hellofresh, Tesla, Novo Nordisk und Zalando - Die Analystenstimmen des Tages | © Foto: Steffen Trumpf/dpaHellofresh, Tesla, Novo Nordisk und Zalando: So bewerten Top-Analysten die Aktien. Ein Überblick.JPMorgan senkt das Kursziel für Hellofresh Die US-Bank JPMorgan hat das Kursziel... ► Artikel lesen | |
AURORA CANNABIS | 3,585 | +1,56 % | Aurora Cannabis Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
CANOPY GROWTH | 1,044 | +0,58 % | Canopy Growth Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
TILRAY BRANDS | 0,350 | +1,92 % | Tilray Brands, Inc.: Tilray Medical erhält vom italienischen Gesundheitsministerium die erste Genehmigung für den Vertrieb von medizinischen Cannabisblüten für therapeutische Zwecke | SAVONA, Italien, June 25, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und weltweit führender Anbieter von medizinischem... ► Artikel lesen | |
VERTEX PHARMACEUTICALS | 378,55 | +0,45 % | Vertex Pharmaceuticals Incorporated (VRTX) Benefited from the Launch of its New Drug | ||
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
BIOTEST | 30,000 | 0,00 % | EQS-News: Biotest AG: Biotest's positive Ergebnisse der Phase III-Studie zu Fibrinogen wurden in der Fachzeitschrift "The Lancet's eClinicalMedicine" veröffentlicht | EQS-News: Biotest AG
/ Schlagwort(e): Konferenz
Biotest's positive Ergebnisse der Phase III-Studie zu Fibrinogen wurden in der Fachzeitschrift "The Lancet's eClinicalMedicine"... ► Artikel lesen | |
CRONOS GROUP | 1,590 | -1,79 % | Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders | TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Friday, June... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
ORGANIGRAM GLOBAL | 1,170 | +0,86 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 02.04.2025 | The following instruments on XETRA do have their first trading 02.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.04.2025
Aktien
1 ROMEDLACNOR6 MedLife S.A.
2 CA29872T2092... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 4,462 | +0,22 % | Green Thumb Industries Reports First Quarter 2025 Results | CHICAGO and VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
MYDECINE INNOVATIONS GROUP | 0,001 | 0,00 % | Mydecine Innovations Group Inc (2): Mydecine Innovations has no material changes | ||
SINOPHARM | 1,981 | -3,34 % | Dividendenbekanntmachungen (16.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AEGON LTD BMG0112X1056 - 0,19 EUR ALTAGAS LTD CA0213611001 0,315 CAD 0,2007 EUR ALTEN SA FR0000071946 - 1,5 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen |